Shimelis, H., Mesman, R. L., Von Nicolai, C., Ehlen, A., Guidugli, L., Martin, C., . . . SURGERY. (2021). BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer. AMER ASSOC CANCER RESEARCH.
استشهاد بنمط شيكاغوShimelis, Hermela, et al. BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer. AMER ASSOC CANCER RESEARCH, 2021.
MLA استشهادShimelis, Hermela, et al. BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer. AMER ASSOC CANCER RESEARCH, 2021.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.